ADC Therapeutics S.A. (ADCT)
NYSE·Healthcare·Biotechnology
$1.30
+5.69%
Mkt Cap $133.55M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
Implied Upside
+170.3%
Consensus $3.50 vs current $1.30
NYSE·Healthcare·Biotechnology
$1.30
+5.69%
Mkt Cap $133.55M
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
+170.3%
Consensus $3.50 vs current $1.30